Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 4
2021 3
2022 8
2023 7
2024 7
2025 7
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J. Vakrakou AG, et al. Among authors: tzanetakos d. Front Immunol. 2023 Jul 26;14:1212757. doi: 10.3389/fimmu.2023.1212757. eCollection 2023. Front Immunol. 2023. PMID: 37564637 Free PMC article. Review.
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Abdelhak A, Bachhuber F, Ning K, Benkert P, John Boscardin W, Maleska Maceski A, Schaedelin S, Achtnichts L, Finkener S, Lalive PH, Uginet M, Pot C, Du Pasquier R, Hoepner R, Chan A, Gobbi C, Zecca C, Müller S, Roth P, Granziera C, Chitnis T, Madill E, Weiner HL, Green AJ, Hauser SL, Cree BA, Kümpfel T, Havla J, Skripuletz T, Gingele S, Senel M, Vardakas I, Taranu D, Ziemann U, Kowarik MC, Kleiter I, Hoshi MM, Zettl UK, Haarmann A, Thebault S, Freedman MS, Bergman HP, Iacobaeus E, Khademi M, Ferraro D, Cardi M, Mariotto S, Comabella M, Montalban X, Vilaseca-Jolonch A, Strijbis EM, Wessels MH, Killestein J, Hemmer B, Held F, Sellebjerg F, Højsgaard Chow H, Alvarez-Lafuente R, Domínguez-Mozo MI, Hegen H, Berek K, Deisenhammer F, Thouvenot E, Agherbi H, Rejdak K, Gąsior M, Tzanetakos D, Tzartos JS, Sormani MP, Dujmovic Basuroski I, Arrambide G, Khalil M, Piehl F, Teunissen CE, Kuhle J, Tumani H. Abdelhak A, et al. Among authors: tzanetakos d. J Neurol Neurosurg Psychiatry. 2025 Oct 15;96(11):1046-1052. doi: 10.1136/jnnp-2025-335831. J Neurol Neurosurg Psychiatry. 2025. PMID: 40506119 Free PMC article.
Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.
Oved K, Denkberg G, Pinzur L, Chroni E, Zouvelou V, Arman I, Mazor RD, Reef S, Harel O, Ntoukaki E, Pechlivanidou M, Ninou E, Tzanetakos D, Salakou S, Chondrogianni M, Daponte A, Rentzos M, Parisis D, Zamba-Papanicolaou E, Pantzaris M, Kleopa KA, Dardiotis E, Vadikolias K, Heliopoulos I, Koutsouraki E, Voumvourakis KI, Konitsiotis S, Giannopoulos S, Grigoriadis NC, Kab T, Friedman Y, Hellmann MA, Alon T, Olmer L, Tsivgoulis G, Lazaridis K, Wilf-Yarkoni A, Tzartos J, Tzartos S. Oved K, et al. Among authors: tzanetakos d. Neurology. 2025 Oct;105(8):e214150. doi: 10.1212/WNL.0000000000214150. Epub 2025 Sep 29. Neurology. 2025. PMID: 41021867 Free PMC article.
Risk of stroke under disease modifying therapies for multiple sclerosis: a systematic review.
Stefanou MI, Theodorou A, Mengel A, Melanis K, Bakirtzis C, Giannopapas V, Kitsos DK, Kowarik M, Feil K, Tzanetakos D, Zouvelou V, Andreadou E, Tzartos JS, Giannopoulos S, Tsivgoulis G. Stefanou MI, et al. Among authors: tzanetakos d. Ther Adv Neurol Disord. 2025 May 21;18:17562864251321669. doi: 10.1177/17562864251321669. eCollection 2025. Ther Adv Neurol Disord. 2025. PMID: 40416416 Free PMC article. Review.
B cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion.
Alexaki A, Baltoumas F, Tzanetakos D, Zografou C, Dame T, Michaletou C, Kyriakaki G, Vakrakou AG, Anagnostouli M, Karadima G, Tzanoudaki M, Dalakas MC, Stefanis L, Kilidireas K, O'Connor KC, Pavlopoulos G, Stathopoulos P. Alexaki A, et al. Among authors: tzanetakos d. J Neuroimmunol. 2026 Apr;413:578854. doi: 10.1016/j.jneuroim.2026.578854. Epub 2026 Jan 5. J Neuroimmunol. 2026. PMID: 41505925
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis.
Stefanou MI, Palaiodimou L, Theodorou A, Christodoulou MV, Tzartos JS, Tzanetakos D, Kitsos D, Chondrogianni M, Zouvelou V, Dardiotis E, Tzavellas E, Syrigou E, Benetou V, Paraskevas GP, Tsiodras S, Tsivgoulis G, Giannopoulos S. Stefanou MI, et al. Among authors: tzanetakos d. Mult Scler. 2023 Apr;29(4-5):585-594. doi: 10.1177/13524585221150881. Epub 2023 Feb 1. Mult Scler. 2023. PMID: 36722184 Free PMC article.
Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in Greece.
Akrivaki A, Tzanetakos D, Gkotzamanis V, Tsogka A, Bakirtzis C, Dimitriadou EM, Theodorou A, Pechlivanidou M, Papakonstantinou A, Skarlatou V, Kitsos D, Stella M, Roussos F, Georgopoulou EM, Kaliontzoglou A, Karathanasis D, Xylogiannopoulou S, Markakis I, Plomaritis P, Stasinaki P, Karamatzianni G, Papantoniou M, Tagaris G, Gryllia M, Angelidakis P, Doskas T, Mastorodemos V, Notas K, Boziki M, Kostadima V, Ellul J, Chroni E, Mitsias P, Evangelopoulos ME, Konitsiotis S, Dardiotis E, Iliopoulos I, Fakas N, Voumvourakis K, Koutsouraki E, Kimiskidis VK, Giannopoulos S, Grigoriadis N, Tsivgoulis G, Tzartos J. Akrivaki A, et al. Among authors: tzanetakos d. Mult Scler Relat Disord. 2025 Dec;104:106768. doi: 10.1016/j.msard.2025.106768. Epub 2025 Sep 19. Mult Scler Relat Disord. 2025. PMID: 41027273
44 results